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Abstract

Methods

Mycobacterium tuberculosis, which is transmitted from human to human
via respiratory droplets, is one of the leading killers among bacterial diseases
in the human body (Center for Disease Control and Prevention, 2012).
Although the cure for this disease is unknown, many advancements have
been made in the right direction . A current focal point in research is how this
bacterium produces ATP via menaquinone pathways, and how it is able to
flourish even in stressful environments. We worked with a specific gene,
Rv2173, which encodes for a product with an unknown chain length. It is
believed that this product plays a role in the biosynthesis of menaquinone.
Gas chromatography-mass spectrometry data indicated that the chain length
of the product is 30 carbons long with a molecular weight of around 420.
Discovering how menaquinone is synthesized is useful because it can lead to
the ability to target and inhibit synthesis, which would render Mycobacterium
tuberculosis dead.

Protein Purification of Rv2173 in E. coli Cells
Transformation of the Rv2173 gene from Mycobacterium tuberculosis
into Escherichia coli C41 cells. 25 μL of E. coli and 2 μL of the DNA were
added to a tube and vortexed, then incubated on ice for 30 minutes. The
mixture was heat shocked for 45 seconds using a 42°C heat block. The
bacteria were fed 250 μL of NZY medium, consisting of 10 g NaCl, 10 g
casein, 5 g yeast extract, and 1 g anhydrous MgSO4 per liter. The tubes
were shaken and incubated at 37°C for an hour and then plated on 50
mg/mL Carbenicillin. To induce protein expression from the cells, another
bacterial transformation was performed into Lucigen C41 cells of E. coli.
After growth on plates was achieved, one colony was inoculated into 5 mL
NZY medium containing 50 mg/mL and grown overnight. Then 1mL of the
suspension was inoculated in 50 mL NZY and grown for 2 hours.
Additionally, 50 mL of NZY was inoculated to 500 mL NZY (50 mg/mL) and
were grown to OD600 = 0.6 - 0.8. The suspension was then put on a shaker
at 16°C . 0.5 mM IPTG was added to allow protein expression, and it was
grown for 16-18 hours. The last step was to harvest by centrifugation at
5000 rpm.
To actually purify the protein, batch purification with Ni-NTA was
performed under denaturing conditions according to manufacturer protocol.
The first step was to add lysis buffer to our tube of cells to re-suspend, and
then transfer the contents to a 50 mL centrifuge tube to vortex. A buffer
Figure 1: Isolated crystal structure of Rv2173 dimer (Courtesy of J.Johnston) containing 8M Urea was used. Then 3 mL of 50% Ni-NTA His-Bind slurry
was added to the tube of lysate and put on a shaker for one hour. The
lysate-resin mixture was then loaded into the column and the flow-through
was collected in a centrifuge tube. The protein was then washed with 8 mL
Buffer C and collected, followed by elution with 2 mL Buffer D and 2 mL
Tuberculosis is a bacterial infection that generally affects the lungs,
Buffer E. The contents of the Buffer E wash was placed in a piece of 15 kD
but can affect other organ systems as well (Center for Disease Control
dialysis tubing (Spectrum Laboratories) and placed in a beaker containing
and Prevention, 2012). Mycobacterium tuberculosis is the group of
8M urea. Every 8 hours the tubing was moved to a decreasing
bacterial cells that cause both the latent and active form of Tuberculosis
concentration of urea: 6M, 4M, 2M, and 0M.
disease in the human body. Mycobacterium tuberculosis is so
SDS-PAGE
dangerous because it can be aerosolized, meaning that the physical
Denaturing SDS-PAGE (Sodium Dodecyl Sulfate Polyacrylamide
bacterial particles can be dispersed into air or gas. This bacterium can
Gel Electrophoresis) was performed to separate the proteins according to
only be contracted if the bacterial droplets are inhaled, where they
individual size and charge. Lane 1 contained the marker, followed by
either lie dormant, the latent form, or begin to reproduce rapidly, the
lysate, flow-through, Buffer C wash, Buffer D wash, and Buffer E wash in
active form. The cases in which the bacterium becomes active only
lane 6. The system was run at 100 V, and the gel was removed and
occurs in people who have compromised immune systems prior to
stained with Commassie Blue G-250.
coming in contact with the bacterial droplets.
Prenyltransferase Assay
There were four total assays, each containing a combination of IPP
and another diphosphate, which was known as the substrate. Each assay
also contained a phosphate buffer, MgCl2, enzyme solution and distilled
water. The first assay contained IPP and DMAPP, the second contained
IPP and GPP, the third contained IPP and FPP and the fourth contained
IPP and GGPP. The amount of diphosphate required was determined
based on their individual molecular weights: 3.14 μL of GPP, 2.46 μL of
IPP, 9.01 μL of GGPP and 2.46 μL of DMAPP. Each assay contained 0.01
Figure 2: Pathway of oxidative phosphorylation including the utilization
mL of MgCl2 and 100 μL of enzyme solution. Based on the different
of quinones (Nelson & Cox 2005) .
amounts of substrate that were water was added to make the total assay
Quinones, which are compounds that are chemically stable, are an
volume equal to 1 mL. Assay 1 contained 785.07 μL , assay 2 contained
important aspect in oxidative metabolism where they easily accommodate
784.4 μL , assay 3 contained 783.72 μL and assay 4 contained 778.52 μL
electrons. Mycobacterium tuberculosis uses oxidative phosphorylation to
of distilled water. At the designated time, the enzyme solution was added to
create ATP through electron transport chain. A key component in the
the cocktail, vortexed and placed back in 37 C heat bath. After 30 minutes
production of ATP via this chain is the use of Menaquinone, the specific
quinone for bacteria (As seen in Figure 2). An unclear aspect to this pathway in the heat bath ~1 mL of 10% Methanol/1 M HCl was added to each assay
is how Mycobacterium tuberculosis is able to create ATP successfully under and they were placed in a heat block at 95 C for 5 minutes. The samples
were then ready to be analyzed by the GC-MS.
any type of environment, including environments with low oxygen. Through
the characterization of the specific gene, Rv2173, researchers can determine
Prenyltransferase Assay Conditions and Results
how this gene plays a role in the biosynthesis of Menaquinone.
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Methods

Assay

Substrate 1

Substrate 2

Product m/z

1

IPP

DMAPP

412

2

IPP

GPP

412

3

IPP

FPP

412

4

IPP

GGPP

412

Protein Assay for Menaquinone Synthesis Analysis
A protein assay including 22 samples was made. Each tube contained a
total volume of 1 mL with 100 μL of cells or protein. Varying amounts of
buffer and different substrates, as demonstrated on chart, were added to
each of the tubes. The samples were done in duplicate, so there were 44
tubes total. Odd numbered tubes contain cells, while even numbered
tubes contain protein. The exact contents of each tube can be seen in
Figure 1. Each substrate had a set amount whenever it was used; IPP =
2.46 μL, GPP = 3.14 μL, FPP = 3.82 μL, GGPP = 9.01 μL, and DMAPP =
2.46 μL. The tubes sat in a 30 C water bath for 30 minutes and then 100
μL of Alkaline Phosphatase was added to each tube.
Table 1: Substrate amounts for HPLC Assay
Sample

Buffer (μL)

Cells/Protein

S1

μL S1

S2

μL S2

S3

μL S3

12

880

100

DHNA

20

x

x

x

x

14

880

100

2HQ

20

x

x

x

x

16
870.99
100
DHNA
20
GGPP
9.01
x
x
HPLC Assay
18
870.99
100
2HQ
20
GGPP
9.01
x
x
Samples are
20
888.53
100
IPP
2.46
GGPP
9.01
DHNA
20
22
888.53
100
IPP
2.46
GGPP
9.01
2HQ
20
analyzed by
injecting 250 μL into the Shimadzu SPD-10AV-VP HPLC equipped with
an octadecyl column (25 cm x 4.6 mm). Once the sample has been
injected the run is started with ten minutes of 0% methanol at 0.200
mL/min. A ramp of 3%/min is used until 90% methanol is reached, then a
ramp of 2%/min is used to 100% methanol. The run is reset by
decreasing to 0% methanol for 10 minutes.

Results
Tagged purification of protein

Figure 4: SDS PAGE of tagged

Figure 5: SDS PAGE of tagged

protein during purification.

Protein during purification.

Figure 4 indicates a darker band stretch across the four lanes to
the right. These were all samples from the buffer E wash, which
was determined to be the most purified wash. Lane 1 to the left
was the marker lane, followed by 2 washes with buffer C. As you
can see, other proteins show on the buffer C lanes because they
were not as purified as the Buffer E washes, which had our
specifically tagged protein purified. Each lane on this gel contained
15 μLof sample.
Figure 5 shows the tagged purification of protein. Starting from the
left is the marker lane. 5 lanes from the left shows a darker dyed
spot around the middle of the gel; this lane contained 10 μLfrom
Buffer E, which is the most purified. This gel also allows for
identification of molecular weight by comparing to marker lane.
The gel indicates that the protein of interest was successfully
tagged.
Enzyme assay resulting in product molecular weight of 412 m/z.
The GC-MS spectra indicates a
peak around a molecular weight of
415 m/z, which corresponds to a
prenyltransferase product of 30
carbon atoms and one alcohol.
However, as this product was
Figure 6: GC-MS analysis of
observed regardless of the
prenyltransferase activity
substrate available to the enzyme, it is questionable whether this is
the true enzymatic product of Rv2173.

HPLC Spectra
Figure 7: Menaquinone

Figure 8: DHNA & GGPP

Figure 9: 2HQ & GGPP

HPLC Spectra allow for identification
of products in a specific sample.
Figure 6 indicates the spectra of
menaquinone, the specific Quinone
that M. Tuberculosis uses in its
electron transport chain, shows a
specific peak at about 53.8 minutes.
Different substrates with similar
structures to menaquinone (seen in
Table 2) were combined to produce
a product that includes
menaquinone. Figure 7 indicates the
spectrum of DHNA combined with
GGPP, which produced a peak at
53.8 minutes, the same as
menaquinone. Figure 8 indicates the
spectrum of 2HQ and GGPP which
also indicates a peak at
approximately 53.8 minutes. Figures
7 & 8 show that there are different
substrates that the bacteria may use
in order to make the menaquinone
necessary for its survival. This
knowledge may help in the discovery
of a drug which can inhibit the
formation of the menaquinone
therefore killing the bacteria.
Table 2: Substrate
names and
structures

Conclusion & Future Directions
Conclusion:
•M. tuberculosis Rv2173 uses isoprenyl substrates to make a
30-carbon isoprenyl alcohol
•Rv2173 attaches GGPP to a napthaquinone ring structure to
synthesize menaquinone-like product
Future Directions:
•Further purify product of 1,4-Dihydroxy-2-napthoic acid with
GGPP and 2-Hydroxy-napthaquinone with GGPP and run
HPLC method to determine if product is indeed like
menaquinone
•Send purified product to a lab for a MALDI-TOF MS to be
completed
•Research mechanism by which product is formed
•Research how a methyl bisphosphonate drug could inhibit
synthesis of menaquinone
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